WelChol And Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
A new study found that taking WelChol(R) (colesevelam HCl) in combination with ezetimibe reduced LDL-C by 32%, reducing mean LDL-C levels by an additional 11% over ezetimibe monotherapy in patients with primary hypercholesterolemia (p [click link for full article] (Source: Cholesterol News From Medical News Today)
Lyme disease map pinpoints high-risk areas: Do you live in one?
Researchers from Yale School of Public Health collected ticks for three years to determine high-risk areas in order to bolster prevention (Source: Health News: CBSNews.com)